SILVER CREEK PHARMACEUTICALS, INC.

Profile

Company Names

SILVER CREEK PHARMACEUTICALS, INC.

Addresses

409 ILLINOIS STREET, SAN FRANCISCO, CA 94158

Phone Numbers

415-978-2178

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$12,570,106.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-01-31 
$9,150,000.00 
$25,000,000.00 
$15,850,000.00 
Equity, Debt 
1
2016-12-04 
$3,420,106.00 
$19,823,283.00 
$16,403,177.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
MARK 
 
AGNE 
DIRECTOR
SILVER CREEK PHARMACEUTICALS, INC.
ROSS 
 
BRECKENRIDGE 
EXECUTIVE OFFICER, DIRECTOR
SENRIGAN MASTER FUND   |  SENRIGAN US FEEDER FUND   |  SENRIGAN FUND LTD   |  SILVER CREEK PHARMACEUTICALS, INC.
LAKHMIR 
 
CHAWLA 
EXECUTIVE OFFICER
EXTHERA MEDICAL CORP   |  SILVER CREEK PHARMACEUTICALS, INC.
MICHAEL 
 
FAIRBANKS 
DIRECTOR
SILVER CREEK PHARMACEUTICALS, INC.
KRIS 
 
KUCHENBECKER 
EXECUTIVE OFFICER
SILVER CREEK PHARMACEUTICALS, INC.
JAMES 
 
MARKS 
DIRECTOR
MIGS LLC   |  SILVER CREEK PHARMACEUTICALS, INC.   |  MISSION READY SOLUTIONS INC   |  WEALTHHUB SOLUTIONS, INC.
JAMES 
D. 
MARKS 
DIRECTOR
SILVER CREEK PHARMACEUTICALS, INC.
THOMAS 
J. 
MURTAGH 
DIRECTOR
SILVER CREEK PHARMACEUTICALS, INC.
TOM 
 
MURTAGH 
DIRECTOR
SILVER CREEK PHARMACEUTICALS, INC.
ULRIK 
 
NIELSEN 
DIRECTOR
SILVER CREEK PHARMACEUTICALS, INC.   |  ALLOY THERAPEUTICS, INC.   |  NOTCH THERAPEUTICS, INC.
BIRGIT 
 
SCHOEBERL 
EXECUTIVE OFFICER, DIRECTOR
SILVER CREEK PHARMACEUTICALS, INC.
NICK 
 
TAYLOR 
DIRECTOR
LOCUS BIOSCIENCES, INC.   |  SILVER CREEK PHARMACEUTICALS, INC.   |  SURGERY CENTER OF WASILLA, LLC   |  HATCHER PASS SURGERY CENTER, LLC   |  SURGERY CENTER OF GEORGETOWN, LLC
TIMOTHY 
 
THROSBY 
EXECUTIVE OFFICER, DIRECTOR
SILVER CREEK PHARMACEUTICALS, INC.   |  PHOENIX CREDIT PARTNERS FUND, LP   |  PHOENIX CREDIT PARTNERS FUND (CAYMAN), LP
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-02-14
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2022-01-31 
2016-12-19
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2016-12-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#